mirror of
https://github.com/soapingtime/diyhrt.git
synced 2026-09-04 20:10:19 +02:00
[automated] update diyhrt.market
This commit is contained in:
@@ -304,7 +304,7 @@ The main downsides of transdermal gel are that some users may have issues with a
|
||||
|
||||
|
||||
|
||||
280 days ago
|
||||
287 days ago
|
||||
|
||||
|
||||
|
||||
@@ -351,7 +351,7 @@ The main downsides of transdermal gel are that some users may have issues with a
|
||||
|
||||
|
||||
|
||||
293 days ago
|
||||
300 days ago
|
||||
|
||||
|
||||
|
||||
@@ -439,7 +439,7 @@ The main downsides of transdermal gel are that some users may have issues with a
|
||||
|
||||
|
||||
|
||||
14 days ago
|
||||
21 days ago
|
||||
|
||||
|
||||
|
||||
@@ -453,7 +453,7 @@ The main downsides of transdermal gel are that some users may have issues with a
|
||||
<a
|
||||
href="../products/gynokadin-dosiergel.html"
|
||||
class="list-group-item list-group-item-action px-2 px-sm-3 py-1"
|
||||
style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
|
||||
style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
|
||||
<div class="row">
|
||||
<div class="col-7 col-sm-4 d-flex align-items-center">
|
||||
<span>
|
||||
@@ -481,9 +481,15 @@ The main downsides of transdermal gel are that some users may have issues with a
|
||||
<div class="col-12 col-sm d-flex justify-content-end text-end align-items-center">
|
||||
|
||||
|
||||
<span class="text-success">
|
||||
<span class="text-danger">
|
||||
|
||||
In Stock
|
||||
|
||||
|
||||
|
||||
4 days ago
|
||||
|
||||
|
||||
|
||||
|
||||
</span>
|
||||
|
||||
@@ -618,5 +624,5 @@ The main downsides of transdermal gel are that some users may have issues with a
|
||||
const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]')
|
||||
const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl))
|
||||
</script>
|
||||
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9131f8088aaeebe9',t:'MTczOTc1NTM3My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body>
|
||||
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'916ba5f96b1208d8',t:'MTc0MDM2MDE4Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body>
|
||||
</html>
|
||||
|
||||
Reference in New Issue
Block a user